SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 7th, 2023 • Marizyme Inc • Pharmaceutical preparations • Florida
This Securities Purchase Agreement (this “Agreement”) is dated as of February 6, 2023, between Marizyme, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
MARIZYME, INC. CLASS D COMMON STOCK PURCHASE WARRANTMarizyme Inc • February 7th, 2023 • Pharmaceutical preparations • Florida
THIS CLASS D COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Walleye Opportunities Master Fund Ltd or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Public Offering Date (as defined in the Securities Purchase Agreement (as defined below)) (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on___________, 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Marizyme, Inc., a Nevada corporation (the “Company”), a number of shares of Common Stock (as subject to adjustment hereunder, the “Warrant Shares”) that is equal to the quotient of the Warrant Value as set forth above divided by the Public Offering Price (as defined below). The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). For purpose of this Warran
